Quarterly report pursuant to Section 13 or 15(d)

SEGMENT REPORTING (Tables)

v3.22.2
SEGMENT REPORTING (Tables)
6 Months Ended
Jun. 30, 2022
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The following table is a comparative summary of the Company’s net sales and segment profit by reportable segment for the periods presented:
Three Months Ended June 30, Six Months Ended June 30,
  2022 2021 2022 2021
Segment Net Sales:
Cannabinoid $ 1,299  $ 579  $ 3,290  $ 1,256 
Non-Cannabinoid 3,358  3,093  6,591  5,893 
Total net sales 4,657  3,672  9,881  7,149 
 
Segment Profit (Loss):
Cannabinoid (5,338) (3,604) (13,026) (6,468)
Non-Cannabinoid 666  634  1,014  1,246 
Total segment loss $ (4,672) $ (2,970) $ (12,012) $ (5,222)
 
Reconciliation:
Total segment loss (4,672) (2,970) (12,012) (5,222)
Unallocated corporate expenses (1,841) (2,786) (5,377) (6,173)
Non-cash share-based compensation (1,148) (3,323) (1,648) (4,873)
Depreciation and amortization (537) (524) (1,054) (1,103)
Loss from continuing operations before income taxes $ (8,198) $ (9,603) $ (20,091) $ (17,371)
 
Loss on debt extinguishment, net   —  —  2,263  — 
(Gain) loss on remeasurement of warrant liability (1,323) (1,176) —  (1,813) 3,675 
Gain on investment (6,851) —  —  (6,851) — 
Foreign exchange loss 307  80  —  652  839 
Interest and amortization of debt issuance cost 652  920  —  2,770  1,898 
Other expense (income), net 63  (485) —  10  (1,087)
Loss before loss from equity investment $ (1,046) $ (8,942) $ (17,122) $ (22,696)
Disaggregation of Revenue
The following table disaggregates the Company’s revenue by channel for the periods presented:

Three Months Ended June 30, Six Months Ended June 30,
2022 2021 2022 2021
Mass retail $ 2,239  $ 1,721  $ 5,236  $ 3,609 
Distributors 1,664  1,448  3,322  2,680 
Specialty, health and other retail 560  350  952  575 
E-commerce 194  153  371  285 
Total $ 4,657  $ 3,672  $ 9,881  $ 7,149 

The following table represents the Company's revenues attributed to countries based on location of customer:
Three Months Ended June 30, Six Months Ended June 30,
2022 2021 2022 2021
United States $ 3,275  $ 3,092  $ 6,508  $ 5,892 
Israel 385  $ 198  $ 1,023  $ 198 
Australia 133  358  684  640 
Brazil 277  920  146 
Germany 408  —  552  — 
Other 179  20  194  273 
 Total $ 4,657  $ 3,672  $ 9,881  $ 7,149 
Schedule of Revenue by Major Customers by Reporting Segments
During the six months ended June 30, 2022 and 2021, the majority of the Company's net sales for the non-cannabinoid segment were in the U.S., with approximately $6.5 million of non-cannabinoid net sales.

Percentage of Revenues Percentage of Accounts Receivable
Three Months Ended June 30, Six Months Ended June 30, June 30, December 31,
2022 2021 2022 2021 2022 2021
Customer A * * * * 20% *
Customer B (a)
* 15% 10% 17% * 25%
Customer C (b)
* * * * 15% 18%
Customer D (a)
* * * * 10% *
Customer E (b)
* * * * 14% *
* denotes less than 10%

(a) net sales attributed are reflected in the non-cannabinoid segments
(b) net sales attributed are reflected in the cannabinoid segments
Long-lived Assets by Geographic Areas
June 30,
2022
December 31,
2021
Long-lived assets
   
Colombia $ 17,146  $ 18,950 
Portugal 12,145  11,733 
Other(a)
211  249 
Total $ 29,502  $ 30,932 
(a)“Other” includes long-lived assets primarily in the U.S.